The U.S. Department of Justice will step into court Monday for its first trial challenging an almost purely vertical merger in 40 years, alleging that AT&T’s planned, $85 billion purchase of Time Warner will give AT&T too much power over rival distributors.
The Senate Judiciary Committee plans to dive into a heated debate over credit card interchange rates and potential antitrust concerns at an upcoming hearing.
In a decision that could affect future white collar cases, a district court judge in Manhattan ruled Tuesday that the government violated the constitutional rights of former KPMG LLP partners by pressuring the firm to not pay their legal fees.
A federal court in Washington, D.C. will decide whether or not to approve the settlements that paved the way for the AT&T/SBC and MCI/Verizon mergers in a hearing scheduled for next month.
Four top Senate judiciary committee members are taking matters into their own hands and introducing legislation to prohibit brand-name drug makers from paying rivals to keep generic drugs off the market.
Rallying against lawmakers, the U.S. Department of Justice’s Antitrust Division and the Federal Trade Commission this week lashed out against proposed legislation that seeks to curb non-lawyers from competing with licensed attorneys in the real estate industry in New York state, saying the move is not in the best interest of consumers.
The European Commission’s antitrust commissioner has confirmed that harsh new penalties are on the horizon for companies that violate the continent’s competition laws, and provided details about how new procedural changes will make that happen.
The European Union’s antitrust watchdog Wednesday is set to revise guidelines for calculating fines, a move that will dramatically increase potential damages for the most prolific violators, according to a Commission insider.
A Swiss competition administration has begun an investigation into three major drug producers that authorities believe may be fixing prices for impotence drugs.
After weeks of wrangling, Adelphia Communications Corp. has finally received permission to sell its assets to Time Warner Corp. and Comcast Corp.
The European Commission has opened a formal investigation of Germany in the wake of the country’s refusal to accept new guidelines for the application of state aid rules to national regional aid.
Less than two weeks after British Airways announced that it was under investigation for alleged price-fixing, a slew of class action lawsuits has already hit the major carrier, as well as other airlines.
As McClatchy Co. and Knight-Ridder Inc. inch towards their multi-billion dollar merger, the U.S. Department of Justice said in a civil antitrust lawsuit filed this week that it will require the merged publishing company to divest the St. Paul Pioneer Press in order to preserve local competition.
In the latest development in a long-running battle that has already cost Microsoft Corp. €497 million in fines, European antitrust authorities are expected to levy yet another staggering fine against the software giant, according to published reports.
More U.S. companies are slipping arbitration clauses into their business contracts, but the putative class action against shipping company Stolt-Nielsen S.A. challenges the common assumption that arbitration is an appropriate and less costly venue for resolving antitrust disputes.
The U.S. Supreme Court agreed on Monday to hear an appeal by U.S. telecommunications giants on a motion to dismiss a class action lawsuit against them that alleges antitrust violations.
The U.S. Department of Justice has issued subpoenas to four orthopedic device makers over possible antitrust violations, a development that sent stock prices tumbling across the orthopedic industry as investors mulled the prospect of upheaval in the multi-billion dollar market.
In a move that could open the floodgates for controversial patent settlement deals between brand-name and generic drug companies, the nation’s highest court Monday turned down the U.S. Federal Trade Commission’s appeal in the closely watched Schering-Plough case.
By deciding to weigh in on a timber buying dispute, the U.S. Supreme Court Monday signaled it’s willing to determine whether it is an antitrust violation for companies to buy materials at inflated prices with the intent of eliminating competition.
Having worked hard in recent years to establish itself as one of the top antitrust practices, international law firm Freshfields Bruckhaus Deringer is now looking to a new pair of lawyers to help build upon that success.
In a case that could influence how the U.S. Federal Trade Commission rules on future settlement agreements over generic drugs, Bristol-Myers Squibb, Sanofi-Aventis and Apotex have altered their settlement over the blockbuster blood thinner Plavix.